Clinical investigation of plasma-derived fibrin sealant/haemostatic products

Current effective version

PDF iconAdopted guideline

Currently under revision - see below

Reference numberCPMP/BPWG/1089/00
Effective from01/01/2005
KeywordsHuman fibrinogen, human thrombin, fibrin sealant
DescriptionThis document summarises the clinical trials required for authorisation of new and modified plasma-derived fibrin sealant/haemostatic products.

Document history

Revision 1

In progress

PDF iconConcept paper Published: 28/05/2014

First version

Current version

PDF iconAdopted guideline

In operation: 01/01/2005–present

Related content


How useful was this page?

Add your rating